Come up with a name for your new list and we'll add to it:
enGene raised a round of funding on January 17, 2004. Investors include
National Research Council Canada.
enGene is a Canadian biotechnology company developing an innovative mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease (IBD) and diabe…